Gabapentin
|
- ₹6596.8 - ₹66876.85
- Product name: Gabapentin
- CAS: 60142-96-3
- MF: C9H17NO2
- MW: 171.24
- EINECS:262-076-3
- MDL Number:MFCD00865286
- Synonyms:GABAPENTIN;GOE-3450;(1-AMINOMETHYL-CYCLOHEXYL)-ACETIC ACID;AKOS 92109;1-(Aminomethyl)-cyclohexaneacetic acid, Neurontin;Goe-3450：GOE-3450：Neurontin;1-(Aminomethyl)cyclohexane-1-acetic acid;Gabapentin (250 mg)G0E0050.999mg/mg(ai)
7 prices
Selected condition：
Brand
- TCI Chemicals (India)
- Sigma-Aldrich(India)
Package
- 10MG
- 50MG
- 1G
- 1ML
- 5G
- 25G
- ManufacturerTCI Chemicals (India)
- Product numberG0318
- Product descriptionGabapentin min. 98.0 %
- Packaging5G
- Price₹7700
- Updated2022-05-26
- Buy
- ManufacturerTCI Chemicals (India)
- Product numberG0318
- Product descriptionGabapentin min. 98.0 %
- Packaging25G
- Price₹23300
- Updated2022-05-26
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberG-007
- Product descriptionGabapentin solution 1.0?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant?
- Packaging1ML
- Price₹6596.8
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberPHR1049
- Product descriptionGabapentin Pharmaceutical Secondary Standard; Certified Reference Material
- Packaging1G
- Price₹10002.3
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product number5.08506
- Product descriptionGabapentin - CAS 60142-96-3 - Calbiochem A water soluble GABA analog that interacts with voltage-gated calcium channels in cortical neurons.
- Packaging10MG
- Price₹12940
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberG154
- Product descriptionGabapentin solid
- Packaging10MG
- Price₹13975.08
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberG154
- Product descriptionGabapentin solid
- Packaging50MG
- Price₹66876.85
- Updated2022-06-14
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| TCI Chemicals (India) | G0318 | Gabapentin min. 98.0 % | 5G | ₹7700 | 2022-05-26 | Buy |
| TCI Chemicals (India) | G0318 | Gabapentin min. 98.0 % | 25G | ₹23300 | 2022-05-26 | Buy |
| Sigma-Aldrich(India) | G-007 | Gabapentin solution 1.0?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant? | 1ML | ₹6596.8 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | PHR1049 | Gabapentin Pharmaceutical Secondary Standard; Certified Reference Material | 1G | ₹10002.3 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | 5.08506 | Gabapentin - CAS 60142-96-3 - Calbiochem A water soluble GABA analog that interacts with voltage-gated calcium channels in cortical neurons. | 10MG | ₹12940 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | G154 | Gabapentin solid | 10MG | ₹13975.08 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | G154 | Gabapentin solid | 50MG | ₹66876.85 | 2022-06-14 | Buy |
Properties
Melting point :162°C
Boiling point :314.4±15.0 °C(Predicted)
Density :1.058±0.06 g/cm3(Predicted)
Flash point :9℃
storage temp. :2-8°C
solubility :H2O: 10 mg/mL
form :solid
pka :pKa1 (25°) 3.68; pKa2 10.70
color :off-white
Merck :14,4319
BRN :2359739
BCS Class :3
Stability :Stable for 1 year from date of purchase as supplied. Solutions in distilled water may be stored at -20°C for up to 3 months.
InChIKey :UGJMXCAKCUNAIE-UHFFFAOYSA-N
CAS DataBase Reference :60142-96-3(CAS DataBase Reference)
EPA Substance Registry System :Cyclohexaneacetic acid, 1-(aminomethyl)- (60142-96-3)
Boiling point :314.4±15.0 °C(Predicted)
Density :1.058±0.06 g/cm3(Predicted)
Flash point :9℃
storage temp. :2-8°C
solubility :H2O: 10 mg/mL
form :solid
pka :pKa1 (25°) 3.68; pKa2 10.70
color :off-white
Merck :14,4319
BRN :2359739
BCS Class :3
Stability :Stable for 1 year from date of purchase as supplied. Solutions in distilled water may be stored at -20°C for up to 3 months.
InChIKey :UGJMXCAKCUNAIE-UHFFFAOYSA-N
CAS DataBase Reference :60142-96-3(CAS DataBase Reference)
EPA Substance Registry System :Cyclohexaneacetic acid, 1-(aminomethyl)- (60142-96-3)
Safety Information
| Symbol(GHS): |
   
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | |||||||||||||||||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
Gabapentin was introduced in 1993 in the UK and early 1994 in the USA as an adjunctive therapy in the treatment of refractory partial seizures and secondarily generalized tonic-clonic seizures. Although being a lipophilic analog of the neurotransmitter GABA, gabapentin appears to exert its anticonvulsive function by a GABA receptor independent mechanism, possibly involving the L-system amino acid transporter protein. Gabapentin easily crosses the blood brain barrier and exhibits a favorable pharmacokinetic profile with high tolerability. It does not interfere with the metabolism of other concomitant administered antiepileptic drugs, thus having a low potential for drug interactions. Studies are currently underway for the use of gabapentin as mono-therapy for the treatment of various seizures.Related product price
- NITROCYCLOHEXANE
₹9000-33900 - Cyclohexylacetic acid
₹2916-130376.3 - Glycyl-glycyl-glycine
₹1640-26870